Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas

We used enzyme‐linked immunosorbent assays (ELISA) to investigate the presence of interleukin‐10 (IL‐10) in the serum of patients developing post‐transplant lymphomas. Serum IL‐10 was detected in 14 out of 19 cases with a lymphoma or Hodgkin's disease, with higher values being observed in patie...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 1999-08, Vol.13 (4), p.305-312
Main Authors: Garnier, Jeanne-Luce, Blanc-Brunat, Nelly, Vivier, Geneviève, Rousset, Françoise, Touraine, Jean-Louis
Format: Article
Language:English
Subjects:
B-cell lymphomas
Biological and medical sciences
Burkitt Lymphoma - blood
Burkitt Lymphoma - etiology
Burkitt Lymphoma - virology
cytokines
EBV latency and replication
Enzyme-Linked Immunosorbent Assay
Genes, Viral
Herpesvirus 4, Human - isolation & purification
Hodgkin's disease
Humans
Immunohistochemistry
In Situ Hybridization
Interleukin-10 - blood
Kidney Failure, Chronic - blood
Kidney Transplantation - adverse effects
Medical sciences
Middle Aged
Miscellaneous
organ transplantation
Prognosis
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tumor Virus Infections - blood
Tumor Virus Infections - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We used enzyme‐linked immunosorbent assays (ELISA) to investigate the presence of interleukin‐10 (IL‐10) in the serum of patients developing post‐transplant lymphomas. Serum IL‐10 was detected in 14 out of 19 cases with a lymphoma or Hodgkin's disease, with higher values being observed in patients who had developed a lymphoma within the first few months post‐transplantation, and who had an aggressive form of the disease. Eleven out of the 14 patients in whom IL‐10 was detected had Epstein–Barr virus‐positive tumors. And 11 out of 14 patients died of lymphomas. In most of the patients who had detectable IL‐10 at the time of diagnosis of the lymphoma, the IL‐10 had not been present previously, but it was found in the serum of 7 out of 9 dialysis patients, and in 8 out of 17 stable transplant patients. We conclude that IL‐10 plays a role in the development of the more severe forms of post‐transplant lymphomas, and may be secreted by tumor cells. However, data from patients with chronic renal failure or patients undergoing immunosuppressive therapy must be treated with caution.
ISSN:0902-0063
1399-0012
DOI:10.1034/j.1399-0012.1999.130405.x